Table 1.
Overall (N=2,096) | # of SAEs = 0 (N=1,351) | # of SAE > 0 (N=745) | P value* | ||||
N (or Mean) | % (or SD) | N (or Mean) | % (or SD) | N (or Mean) | % (or SD) | ||
Age at AD diagnosis | 77.2 | 9.7 | 77.0 | 9.5 | 77.7 | 9.9 | 0.0973a |
Age at first donepezil | 78.2 | 9.7 | 78.0 | 9.6 | 78.5 | 9.9 | 0.2303a |
Gender | 0.4499b | ||||||
Female | 1328 | 63.4% | 848 | 62.8% | 480 | 64.4% | |
Male | 768 | 36.6% | 503 | 37.2% | 265 | 35.6% | |
Race/Ethnicity | <.0001b | ||||||
NHW | 1050 | 50.1% | 706 | 52.3% | 344 | 46.2% | |
NHB | 408 | 19.5% | 215 | 15.9% | 193 | 25.9% | |
Hispanic | 563 | 26.9% | 376 | 27.8% | 187 | 25.1% | |
Other | 75 | 3.6% | 54 | 4.0% | 21 | 2.8% | |
Median | IQR | Median | IQR | Median | IQR | ||
Number of donepezil prescriptions | 2.0 | (1.0, 3.0) | 1.0 | (1.0, 2.0) | 2.0 | (1.0, 4.0) | <.0001c |
Number of months on donepezil | 0.0 | (0.0, 6.6) | 0.0 | (0.0, 0.9) | 1.6 | (0.0, 17.0) | <.0001c |
The p value was for the comparison between the # of SAEs = 0 and # of SAE > 0 group
two samples T test;
Chi-square test;
Wilcoxon rank sum test;